List of Tables
Table 1. Global Medications for Alzheimer's Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Medications for Alzheimer's Disease Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Medications for Alzheimer's Disease Market Competitive Situation by Manufacturers in 2023
Table 4. Global Medications for Alzheimer's Disease Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Medications for Alzheimer's Disease Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Medications for Alzheimer's Disease Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Medications for Alzheimer's Disease Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Medications for Alzheimer's Disease Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Medications for Alzheimer's Disease, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medications for Alzheimer's Disease, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medications for Alzheimer's Disease, Product Type & Application
Table 12. Global Key Manufacturers of Medications for Alzheimer's Disease, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medications for Alzheimer's Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Alzheimer's Disease as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medications for Alzheimer's Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Medications for Alzheimer's Disease Sales by Region (2019-2024) & (K Units)
Table 18. Global Medications for Alzheimer's Disease Sales Market Share by Region (2019-2024)
Table 19. Global Medications for Alzheimer's Disease Sales by Region (2025-2030) & (K Units)
Table 20. Global Medications for Alzheimer's Disease Sales Market Share by Region (2025-2030)
Table 21. Global Medications for Alzheimer's Disease Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Medications for Alzheimer's Disease Revenue Market Share by Region (2019-2024)
Table 23. Global Medications for Alzheimer's Disease Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Medications for Alzheimer's Disease Revenue Market Share by Region (2025-2030)
Table 25. North America Medications for Alzheimer's Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Medications for Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 27. North America Medications for Alzheimer's Disease Sales by Country (2025-2030) & (K Units)
Table 28. North America Medications for Alzheimer's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Medications for Alzheimer's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Medications for Alzheimer's Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Medications for Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 32. Europe Medications for Alzheimer's Disease Sales by Country (2025-2030) & (K Units)
Table 33. Europe Medications for Alzheimer's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Medications for Alzheimer's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Medications for Alzheimer's Disease Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Medications for Alzheimer's Disease Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Medications for Alzheimer's Disease Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Medications for Alzheimer's Disease Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Medications for Alzheimer's Disease Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Medications for Alzheimer's Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Medications for Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Medications for Alzheimer's Disease Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Medications for Alzheimer's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Medications for Alzheimer's Disease Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Medications for Alzheimer's Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Medications for Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Medications for Alzheimer's Disease Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Medications for Alzheimer's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Medications for Alzheimer's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Medications for Alzheimer's Disease Sales (K Units) by Type (2019-2024)
Table 51. Global Medications for Alzheimer's Disease Sales (K Units) by Type (2025-2030)
Table 52. Global Medications for Alzheimer's Disease Sales Market Share by Type (2019-2024)
Table 53. Global Medications for Alzheimer's Disease Sales Market Share by Type (2025-2030)
Table 54. Global Medications for Alzheimer's Disease Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Medications for Alzheimer's Disease Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Medications for Alzheimer's Disease Revenue Market Share by Type (2019-2024)
Table 57. Global Medications for Alzheimer's Disease Revenue Market Share by Type (2025-2030)
Table 58. Global Medications for Alzheimer's Disease Price (US$/Unit) by Type (2019-2024)
Table 59. Global Medications for Alzheimer's Disease Price (US$/Unit) by Type (2025-2030)
Table 60. Global Medications for Alzheimer's Disease Sales (K Units) by Application (2019-2024)
Table 61. Global Medications for Alzheimer's Disease Sales (K Units) by Application (2025-2030)
Table 62. Global Medications for Alzheimer's Disease Sales Market Share by Application (2019-2024)
Table 63. Global Medications for Alzheimer's Disease Sales Market Share by Application (2025-2030)
Table 64. Global Medications for Alzheimer's Disease Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Medications for Alzheimer's Disease Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Medications for Alzheimer's Disease Revenue Market Share by Application (2019-2024)
Table 67. Global Medications for Alzheimer's Disease Revenue Market Share by Application (2025-2030)
Table 68. Global Medications for Alzheimer's Disease Price (US$/Unit) by Application (2019-2024)
Table 69. Global Medications for Alzheimer's Disease Price (US$/Unit) by Application (2025-2030)
Table 70. Eisai Company Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Eisai Medications for Alzheimer's Disease Product
Table 74. Eisai Recent Developments/Updates
Table 75. Biogen Company Information
Table 76. Biogen Description and Business Overview
Table 77. Biogen Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Biogen Medications for Alzheimer's Disease Product
Table 79. Biogen Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly Medications for Alzheimer's Disease Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Otsuka Pharmaceutical Company Information
Table 86. Otsuka Pharmaceutical Description and Business Overview
Table 87. Otsuka Pharmaceutical Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Otsuka Pharmaceutical Medications for Alzheimer's Disease Product
Table 89. Otsuka Pharmaceutical Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AbbVie Medications for Alzheimer's Disease Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Aurobindo Pharma Company Information
Table 96. Aurobindo Pharma Description and Business Overview
Table 97. Aurobindo Pharma Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Aurobindo Pharma Medications for Alzheimer's Disease Product
Table 99. Aurobindo Pharma Recent Developments/Updates
Table 100. Sun Pharma Company Information
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sun Pharma Medications for Alzheimer's Disease Product
Table 104. Sun Pharma Recent Developments/Updates
Table 105. Zydus Company Information
Table 106. Zydus Description and Business Overview
Table 107. Zydus Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zydus Medications for Alzheimer's Disease Product
Table 109. Zydus Recent Developments/Updates
Table 110. Sandoz Company Information
Table 111. Sandoz Description and Business Overview
Table 112. Sandoz Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Sandoz Medications for Alzheimer's Disease Product
Table 114. Sandoz Recent Developments/Updates
Table 115. Dr. Reddy's Laboratories Company Information
Table 116. Dr. Reddy's Laboratories Description and Business Overview
Table 117. Dr. Reddy's Laboratories Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Dr. Reddy's Laboratories Medications for Alzheimer's Disease Product
Table 119. Dr. Reddy's Laboratories Recent Developments/Updates
Table 120. Chartwell Company Information
Table 121. Chartwell Description and Business Overview
Table 122. Chartwell Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Chartwell Medications for Alzheimer's Disease Product
Table 124. Chartwell Recent Developments/Updates
Table 125. Cipla Company Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Cipla Medications for Alzheimer's Disease Product
Table 129. Cipla Recent Developments/Updates
Table 130. Macleods Pharmaceuticals Company Information
Table 131. Macleods Pharmaceuticals Description and Business Overview
Table 132. Macleods Pharmaceuticals Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Macleods Pharmaceuticals Medications for Alzheimer's Disease Product
Table 134. Macleods Pharmaceuticals Recent Developments/Updates
Table 135. Lupin Company Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Lupin Medications for Alzheimer's Disease Product
Table 139. Lupin Recent Developments/Updates
Table 140. Hetero Company Information
Table 141. Hetero Description and Business Overview
Table 142. Hetero Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Hetero Medications for Alzheimer's Disease Product
Table 144. Hetero Recent Developments/Updates
Table 145. Amneal Pharmaceuticals Company Information
Table 146. Amneal Pharmaceuticals Description and Business Overview
Table 147. Amneal Pharmaceuticals Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Amneal Pharmaceuticals Medications for Alzheimer's Disease Product
Table 149. Amneal Pharmaceuticals Recent Developments/Updates
Table 150. Apotex Company Information
Table 151. Apotex Description and Business Overview
Table 152. Apotex Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Apotex Medications for Alzheimer's Disease Product
Table 154. Apotex Recent Developments/Updates
Table 155. Watson Labs Company Information
Table 156. Watson Labs Description and Business Overview
Table 157. Watson Labs Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Watson Labs Medications for Alzheimer's Disease Product
Table 159. Watson Labs Recent Developments/Updates
Table 160. Sinopharm Company Information
Table 161. Sinopharm Description and Business Overview
Table 162. Sinopharm Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Sinopharm Medications for Alzheimer's Disease Product
Table 164. Sinopharm Recent Developments/Updates
Table 165. Zhejiang Jingxin Pharmaceutical Company Information
Table 166. Zhejiang Jingxin Pharmaceutical Description and Business Overview
Table 167. Zhejiang Jingxin Pharmaceutical Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Zhejiang Jingxin Pharmaceutical Medications for Alzheimer's Disease Product
Table 169. Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
Table 170. Hisun Pharmaceuticals Company Information
Table 171. Hisun Pharmaceuticals Description and Business Overview
Table 172. Hisun Pharmaceuticals Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Hisun Pharmaceuticals Medications for Alzheimer's Disease Product
Table 174. Hisun Pharmaceuticals Recent Developments/Updates
Table 175. Hansoh Pharma Company Information
Table 176. Hansoh Pharma Description and Business Overview
Table 177. Hansoh Pharma Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Hansoh Pharma Medications for Alzheimer's Disease Product
Table 179. Hansoh Pharma Recent Developments/Updates
Table 180. Yangtze River Pharmaceutical Company Information
Table 181. Yangtze River Pharmaceutical Description and Business Overview
Table 182. Yangtze River Pharmaceutical Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Yangtze River Pharmaceutical Medications for Alzheimer's Disease Product
Table 184. Yangtze River Pharmaceutical Recent Developments/Updates
Table 185. Yichang Humanwell Pharmaceutical Company Information
Table 186. Yichang Humanwell Pharmaceutical Description and Business Overview
Table 187. Yichang Humanwell Pharmaceutical Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Yichang Humanwell Pharmaceutical Medications for Alzheimer's Disease Product
Table 189. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 190. CSPC Ouyi Pharmaceutical Company Information
Table 191. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 192. CSPC Ouyi Pharmaceutical Medications for Alzheimer's Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 193. CSPC Ouyi Pharmaceutical Medications for Alzheimer's Disease Product
Table 194. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Medications for Alzheimer's Disease Distributors List
Table 198. Medications for Alzheimer's Disease Customers List
Table 199. Medications for Alzheimer's Disease Market Trends
Table 200. Medications for Alzheimer's Disease Market Drivers
Table 201. Medications for Alzheimer's Disease Market Challenges
Table 202. Medications for Alzheimer's Disease Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medications for Alzheimer's Disease
Figure 2. Global Medications for Alzheimer's Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Medications for Alzheimer's Disease Market Share by Type: 2023 & 2030
Figure 4. Cholinesterase Inhibitors Product Picture
Figure 5. Anti-amyloid Antibodies Product Picture
Figure 6. Memantine Product Picture
Figure 7. Brexpiprazole Product Picture
Figure 8. Others Product Picture
Figure 9. Global Medications for Alzheimer's Disease Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Medications for Alzheimer's Disease Market Share by Application: 2023 & 2030
Figure 11. Early-stage Alzheimer's
Figure 12. Middle-stage Alzheimer's
Figure 13. Late-stage Alzheimer's
Figure 14. Global Medications for Alzheimer's Disease Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Medications for Alzheimer's Disease Market Size (2019-2030) & (US$ Million)
Figure 16. Global Medications for Alzheimer's Disease Sales (2019-2030) & (K Units)
Figure 17. Global Medications for Alzheimer's Disease Average Price (US$/Unit) & (2019-2030)
Figure 18. Medications for Alzheimer's Disease Report Years Considered
Figure 19. Medications for Alzheimer's Disease Sales Share by Manufacturers in 2023
Figure 20. Global Medications for Alzheimer's Disease Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Medications for Alzheimer's Disease Players: Market Share by Revenue in Medications for Alzheimer's Disease in 2023
Figure 22. Medications for Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Medications for Alzheimer's Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Medications for Alzheimer's Disease Sales Market Share by Country (2019-2030)
Figure 25. North America Medications for Alzheimer's Disease Revenue Market Share by Country (2019-2030)
Figure 26. United States Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Medications for Alzheimer's Disease Sales Market Share by Country (2019-2030)
Figure 29. Europe Medications for Alzheimer's Disease Revenue Market Share by Country (2019-2030)
Figure 30. Germany Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Medications for Alzheimer's Disease Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Medications for Alzheimer's Disease Revenue Market Share by Region (2019-2030)
Figure 37. China Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Medications for Alzheimer's Disease Sales Market Share by Country (2019-2030)
Figure 45. Mexico Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Medications for Alzheimer's Disease Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Medications for Alzheimer's Disease Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Medications for Alzheimer's Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Medications for Alzheimer's Disease by Type (2019-2030)
Figure 55. Global Revenue Market Share of Medications for Alzheimer's Disease by Type (2019-2030)
Figure 56. Global Medications for Alzheimer's Disease Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Medications for Alzheimer's Disease by Application (2019-2030)
Figure 58. Global Revenue Market Share of Medications for Alzheimer's Disease by Application (2019-2030)
Figure 59. Global Medications for Alzheimer's Disease Price (US$/Unit) by Application (2019-2030)
Figure 60. Medications for Alzheimer's Disease Value Chain
Figure 61. Medications for Alzheimer's Disease Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
